Supplier Type
- Manufacturer
- Reagent
- Trader
- contract manufacturer
- custom synthesis
Supplier Region
- Hyderabad(11)
- Maharashtra(8)
- Gujarat(11)
- Mumbai(14)
- Ahmedabad(4)
- Tamil Nadu(1)
- Bangalore(1)
- Pune(3)
- New Delhi(1)
- Vadodara(3)
- Delhi(1)
- Karnataka(1)
- Telangana(1)
- Nagpur(1)
Purity
- NLT 95%
- more than 90%
- Greater than 99%
- ABOVE 99%
- 99.96%
- 99.95%
- 99.80%
- 99.73%
- 99.55%
- 99.36%
- 99.18%
- 99% Minimum
- > 99%
- 99%
- 98%
- 98 %
- 97-99%
- 97.84%
- 97%
- 96.40%
- 96.39%
- 96.00 % Min
- 96%
- 95.00%
- 95.00 % Min
- 95%
- >95%
- 93.0 % Min
- >92%
- 90-95%
- 90%
- >90%
- 90 % Min.
- 90 % Above
- 86.74%
- 68.0 % Min
- 65%
- 25 MG 50 MG 100 MG 250 MG EXTRA
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1kg
- 5kg
- 10kg
- 25kg
- 500kg
- 1and gm
- 1MT
- 95NLT %
- 250250 mg.
-
CITALOPRAM RELATED COMPOUND F (200 MG) (DIMETHYL-(1-METHYL-3,3-DIPHENYL-ALLYL)-AMINE HYDROCHLORIDE)
55011-89-7
-
3-INDOXYL PHOSPHATE, DI-P-TOLUIDINIUM SALT
103404-81-5
-
NAPHTHA STANDARD MIX
-
3-Hydroxy CitalopraM
411221-53-9
-
1-(3-Chlorophenyl)-1-hydroxy-2-propanone
857233-13-7
-
Cyclobenzaprine N-Oxide
6682-26-4
-
Tigecycline (open C-ring D-ring) Quinone
1268494-46-7
-
2,2'-(4,4'-(3,3'-(isopropylazanediyl)bis(2-hydroxypropane-3,1-diyl))bis(oxy)bis(4,1-phenylene))diacetaMide
87619-83-8
-
N-Methylparoxetine
110429-36-2
Citalopram Related Compound F 55011-89-7
Tigecycline USP Related Compound F 1268494-46-7
PAROXETINE USP RELATED COMPOUND F 110429-36-2
>90% Zolmitriptan USP Related Compound F, 25mg, Industrial Grade 1350928-05-0
Citalopram hydrobromide 59729-32-7
Dibenzo[b,f][1,4]-thiazepin-11(10H)-one 3159-07-7
Citalopram 59729-33-8
4-Chloropyrrolo[2,1-f][1,2,4]triazine 888720-29-4
Citalopram hydrobromide 59729-32-7
Dibenzo[b,f][1,4]-thiazepin-11(10H)-one 3159-07-7